Healthcare data and analytics and tech-enabled services will be the sectors most impacted by generative AI, according to a survey by investment firm GSR Ventures.
The survey, which included responses from more than 40 healthcare technology venture capitalists, found that over 71% believe ChatGAPT/GenAI changes their investment strategy "somewhat" or "a little." In contrast, 12% say it affects...
After digital health startups scooped up huge amounts of investor dollars last year, the market slowed down significantly in 2022. But it's still a relatively new field, and there's plenty of room for startups that can prove their ability to improve care, says John Beadle, managing partner at Aegis Ventures.
He sat down with MobiHealthNews to discuss the growth in partnerships with health systems...
After a year of mega-rounds, skyrocketing valuations and a parade of growing digital health startups, the investment landscape looked a lot more tepid in 2022.
But there are still plenty of opportunities for startups, especially for companies that can demonstrate their value amid a challenging economic environment, said Dr. Sunny Kumar, partner at GSR Ventures. Kumar sat down with MobiHealthNews...
Teletherapy company Talkspace is facing a class action lawsuit alleging it misled investors about the company's financials in the run-up to its merger with a special purpose acquisition company.
The suit, filed Jan. 7, alleges investors weren't informed that Talkspace was seeing significantly increased advertising costs in its direct-to-consumer business, and it was seeing lower conversion rates...
Digital health funding hit new heights in 2021. According to Rock Health’s Q3 report, funding had already hit $21.3 billion across 541 deals this year. Average funding amounts for Series A, B and C+ rounds have grown more than two times since 2017.
With that huge growth in mind, MobiHealthNews asked executives and other leaders in the digital health space about funding in 2021. How will it...
TailorMed, a platform that allows healthcare providers to manage their finances, check health plans and estimate out-of-pocket costs for uninsured patients, has acquired fellow financial management company Vivor.
TailorMed’s tool also automates the process of identifying patients who may need financial assistance and connects them with resources like government subsidies and programs, co-pay...
Pear Therapeutics’ reSET-O prescription digital therapeutic for opioid use disorder lowered healthcare costs and added quality life years post-treatment, according to a Pear-funded analysis published in the Journal of Market Access & Health Policy.
TOP-LINE DATA
Over 12 weeks, using reSET-O in addition to treatment as usual lowered costs by $1,014 and added 0.003 quality-adjusted life years...
Pear Therapeutics' reSET-O, a prescription app for treating opioid use disorder, may lower patients’ health care costs, compared with patients who don’t use the app, according to a study published in the journal Hospital Practice.
“Engagement and continued treatment with reSET-O in patients with OUD treated with buprenorphine is associated with substantial real-world reductions in medical costs...
Amid the growing digital health ecosystem, Collective Health is making it easier for employers to manage their various offerings through its new Premier Partnership Program.
The program brings together some of the leading digital health companies to help employers curate, integrate, measure impact and drive engagement with their virtual offerings.
Specifically, Collective Health will give support...
Fueled by the raising awareness of women’s health needs caused by the COVID-19 pandemic, the global femtech market is expected to reach $1.15 billion by 2025, according to a Frost & Sullivan study.
In 2020, the femtech market represented $648 million, meaning over the next five years it will have a compound annual growth rate (CAGR) of 12.2%, according to the analysts.
Driving this growth...
